Undecimal Bio
a spin-out from Eleven Therapeutics advancing targeted delivery of siRNA therapeutics
Amount raised
$18M
Round
Seed
Date raised
October 12, 2026
Founded
—
CompanyUndecimal Bio
IndustryBiotechnology
LocationCambridge, United Kingdom
Investors4BIO Capital, IQ Capital
Websiteundecimalbio.com
Founders
Get new raises like this every week
Free weekly list of newly funded startups and their founders.
About Undecimal Bio
a spin-out from Eleven Therapeutics advancing targeted delivery of siRNA therapeutics
- How much did Undecimal Bio raise?
- Undecimal Bio raised $18M in a Seed round on October 12, 2026. Investors include 4BIO Capital, IQ Capital.
- Who founded Undecimal Bio?
- Yaniv Erlich and Shaul Ilan co-founded Undecimal Bio.
- Where is Undecimal Bio based?
- Undecimal Bio is based in Cambridge, United Kingdom.